Showing 5031-5040 of 5693 results for "".
- Allergan COVID-19 Response: Program Enhancementshttps://modernod.com/news/allergan-covid-19-response-program-enhancements/2477507/Allergan has announced several program enhancements designed to assist eye care professionals and patients during the COVID-19 pandemic. These include: Lowering copay savings card offerings for Restas
- CAD4COVID: X-Ray Analysis for Quick Triage in Corona Crisishttps://modernod.com/news/cad4covid-x-ray-analysis-for-quick-triage-in-corona-crisis/2477508/Thirona and Delft Imaging launched CAD4COVID, a new artificial intelligence tool that analyzes X-ray images and is intended to support healthcare specialists manage COVID-19 cases. The companies
- Second Sight Announces Employee Layoffs, Intent to Wind Down Operationshttps://modernod.com/news/second-sight-announces-employee-layoffs-intent-to-wind-down-operations/2477503/Implantable visual prosthetics maker Second Sight Medical Products, announced that in response to the impact of the global COVID-19 pandemic on its ability to secure financing, the company decided to pursue an ord
- ProQR Announces Positive Findings From an Interim Analysis in the Phase 1/2 trial of QR-421a for Usher Syndrome and Provides Business Updatehttps://modernod.com/news/proqr-announces-positive-findings-from-an-interim-analysis-in-the-phase-1-2-trial-of-qr-421a-for-usher-syndrome-and-provides-business-update/2477500/ProQR Therapeutics announced positive findings from a planned 3-month interim analysis of its Phase 1/2 Stellar trial of QR-421a in adults with Usher syndrome and non-syndromic retinitis pigmentosa (nsRP) due to USH2A exon 13 mutations. The company is also providing an update
- SECO International Names Dr. R. Max Raynor as 2021 Presidenthttps://modernod.com/news/seco-international-names-dr-r-max-raynor-as-2021-president/2477497/SECO International has named R. Max Raynor, OD, as the next president. His term began on March 7, 2020, and will last through February 28, 2021. Dr. Raynor officially accepted the honor during the House of Delegates meeting held on Saturday, March 7 at SECO 20/20. “Dr. Raynor has dedicated
- FDA Approves Anti-Malarial Drugs Chloroquine And Hydroxychloroquine For Emergency Coronavirus Treatmenthttps://modernod.com/news/fda-approves-anti-malarial-drugs-chloroquine-and-hydroxychloroquine-for-emergency-coronavirus-treatment/2477496/The Food and Drug Administration on Sunday issued an emergency authorization for experimental coronavirus treatments using chloroquine and hydroxychloroquine, anti-malaria drugs touted by President Donald Trump despite inconclusive clinical proof of their effectiveness, according to a Forbes
- Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19https://modernod.com/news/johnson-johnson-announces-a-lead-vaccine-candidate-for-covid-19/2477489/Johnson & Johnson announced a $1 billion deal with the U.S. government to create enough manufacturing capacity to make more than 1 billion doses of a potential vaccine for COVID-19. Johnson & Johnson said on Monday it has been working on a vaccine since January 2020 and expects to initiat
- The Allergan Foundation Donates $2 Million to Community Organizations on Front Line of COVID-19 Responsehttps://modernod.com/news/the-allergan-foundation-donates-2-million-to-community-organizations-on-front-line-of-covid-19-response/2477485/Allergan announced that The Allergan Foundation has awarded approximately $13 million in charitable grants in 2020. The 2020 donations support programs dedicated to the COVID-19 pandemic response, as well as initiatives supporting mental health, eye care, and breast
- Sun Pharmaceutical Donates 2.5 Million Hydroxychloroquine Sulfate Tablets in the US For Potential COVID-19 Treatmenthttps://modernod.com/news/sun-pharmaceutical-donates-2-5-million-hydroxychloroquine-sulfate-tablets-in-the-us-for-potential-covid-19-treatment/2477480/Sun Pharmaceutical Industries announced that it has donated 2.5 million hydroxychloroquine sulfate tablets for use in the United States. Sun Pharma is seeking to enable health care experts meet the growing patient demands for this product as they assess its potential to treat COVID-19 through cli
- Eyewire News Exclusive: Q&A With Anne Coleman, MD, PhD, President of AAOhttps://modernod.com/news/eyewire-news-exclusive-qa-with-anne-coleman-md-phd-president-of-aao/2477474/The American Academy of Ophthalmology (AAO) continues to update its guidance for ophthalmologists dealing with the COVID-19 pandemic. Most recently, AAO updated its guidance on vaccine and t